These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18645712)

  • 1. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
    Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between body mass and postmenopausal symptoms in surgically castrated women.
    Dragojević S; Mitrović A; Jovanović T; Dikić S
    Arch Gynecol Obstet; 2005 Mar; 271(3):240-2. PubMed ID: 15014949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estradiol valerate and levonorgestrel on vaginal health.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
    Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking and vaginal atrophy in postmenopausal women.
    Kalogeraki A; Tamiolakis D; Relakis K; Karvelas K; Froudarakis G; Hassan E; Martavatzis N; Psaroudakis E; Matalliotakis J; Makrigiannakis A; Koumantakis E; Delides G
    In Vivo; 1996; 10(6):597-600. PubMed ID: 8986469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and outcome of ASC-H-interpreted cervical smears in postmenopausal women.
    Ahn S; Lee YY; Sung JY; Lee JJ; Oh YL; Sung CO; Song SY
    Acta Cytol; 2012; 56(3):259-65. PubMed ID: 22555527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goblet-like cells in atrophic vaginal smears and their histologic correlation. Possible confusion with endocervical cells.
    Koike N; Higuchi T; Sakai Y
    Acta Cytol; 1990; 34(6):785-8. PubMed ID: 1701599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
    Delmanto A; Nahas-Neto J; Nahas EA; de Oliveira ML; Fernandes CE; Traiman P
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-acting oestriol on the vaginal cytology of postmenopausal women.
    Purola E; Vartiainen E
    Ann Chir Gynaecol; 1977; 66(4):216-8. PubMed ID: 907314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
    Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
    Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
    Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial.
    Manonai J; Songchitsomboon S; Chanda K; Hong JH; Komindr S
    Maturitas; 2006 May; 54(2):135-40. PubMed ID: 16297576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.